Treatment impact on COVID-19 evolution in hemodialysis patients
- 1 August 2020
- journal article
- letter
- Published by Elsevier BV in Kidney International
- Vol. 98 (4), 1053-1054
- https://doi.org/10.1016/j.kint.2020.07.010
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Covid-19 and Kidney TransplantationThe New England Journal of Medicine, 2020
- Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19The New England Journal of Medicine, 2020
- Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19The New England Journal of Medicine, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Imbalanced plasma ACE and ACE2 level in the uremic patients with cardiovascular diseases and its change during a single hemodialysis sessionRenal Failure, 2017
- Some Aspects of the Renin-Angiotensin-System in Hemodialysis PatientsKidney and Blood Pressure Research, 2015
- Angiotensin-converting enzyme 2 activity in patients with chronic kidney diseaseNephrology Dialysis Transplantation, 2013